Breaking News Instant updates and real-time market news.

2018-11-06 10:11:22 IIN IntriCon $36.77 -7.585 (-17.10%) , MDT Medtronic $91.89 0.3 (0.33%) 10:11 11/06/18 11/06 10:11 11/06/18 10:11	Stifel still upbeat on IntriCon's long-term prospects after Q3 report Stifel analyst Jonathan Block said IntriCon's (IIN) stock might see some selling pressure after the company's Q3 revenue of $30.1M came in modestly below his $30.5M forecast, but he remains upbeat on the company's long-term prospects given his view that it is still very early in the process of IntriCon benefiting from Medtronic's (MDT) 670G/690G product cycles. Block keeps a Buy rating and $70 price target on shares of IntriCon, which are down $9.77, or 22%, to $34.52 in morning trading. IIN IntriCon $36.77 -7.585 (-17.10%) MDT Medtronic $91.89 0.3 (0.33%)
IIN MDT IIN IntriCon $36.77 -7.585 (-17.10%) 08/22/18 RILY 08/22/18 NO CHANGE Target $73 RILY Buy IntriCon price target raised to $73 from $62 at B. Riley FBR B. Riley FBR analyst Andrew D'Silva raised his price target for IntriCon to $73 to reflect revised share count assumptions and stronger diabetes/hearing aid growth. The analyst maintains a Buy rating on the shares following the company's $95M equity offering. 09/11/18 DOTC 09/11/18 DOWNGRADE DOTC Neutral IntriCon downgraded to Neutral from Buy at Dougherty 09/17/18 RILY 09/17/18 NO CHANGE Target $73 RILY Buy IntriCon 22% pullback brings 'unique entry point,' says B. Riley FBR B. Riley FBR analyst Andrew D'Silva believes the 22% pullback in shares of IntriCon since September 10 provide a "unique entry point." The analyst continues to believe that market does not fully understand what improved attachment rates could mean for IntriCon's bottom line. He keeps a Buy rating on the shares with a $73 price target. 09/21/18 STFL 09/21/18 NO CHANGE Target $70 STFL Buy IntriCon price target raised to $70 from $65 at Stifel Stifel analyst Jonathan Block raised his price target on IntriCon (IIN) to $70 from $65 by assigning what he called "relatively conservative sales multiples" to his forecasts for the company's Medical and Hearing businesses, but he also contends that margin expansion will play an important part to IntriCon's story in the coming years, giving the stock a path toward $100 per share. Block, who believes IntriCon's traction with Medtronic (MDT) gives it a long runway for growth, keeps a Buy rating on the shares. MDT Medtronic $91.89 0.3 (0.33%) 10/15/18 LEHM 10/15/18 INITIATION LEHM Overweight Medtronic initiated with an Overweight at Barclays Barclays analyst Kristen Stewart initiated Medtronic with an Overweight rating and $113 price target. 10/16/18 LEHM 10/16/18 INITIATION LEHM Barclays starts MedTech sector with Positive view Barclays analyst Kristen Stewart last night initiated coverage of the MedTech sector with a Positive view. The analyst expects the MedTech market to grow 4%-5% "for the foreseeable future" and believes the recent increase in price-to-earnings multiples in the space is warranted given the improving fundamentals. Looking ahead, she thinks relative P/E multiples "should be at least maintained." Stewart initiated coverage on 12 stocks, with Overweight ratings on Abbott (ABT), Boston Scientific (BSX) Stryker (SYK) and Medtronic (MDT). The analyst put Underweight ratings on Baxter (BAX), Edwards Lifesciences (EW) and Zimmer Biomet (ZBH). 10/16/18 10/16/18 INITIATION On The Fly: Top five analyst initiations Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Abbott (ABT), Boston Scientific (BSX), Stryker (SYK), and Medtronic (MDT) were initiated with an Overweight at Barclays, while Baxter (BAX), Edwards Lifesciences (EW), and Zimmer Biomet (ZBH) were initiated with an Underweight. 2. Expedia (EXPE) was initiated with an Outperform at Evercore ISI, while TripAdvisor (TRIP) was initiated with an In Line, and Booking Holdings (BKNG) was initiated with an In Line. 3. Facebook (FB) was initiated with a Buy at Loop Capital and Rosenblatt. 4. Snap (SNAP) initiated with a Hold at Loop Capital. 5. VF Corp. (VFC) initiated with a Neutral at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here. 11/05/18 PIPR 11/05/18 NO CHANGE PIPR Overweight Globus Medical unlikely to be hurt by Medtronic approval, says Piper Jaffray Piper Jaffray analyst Matt O'Brien noted that Medtronic (MDT) and Mazor Robotics (MZOR) received FDA 510K approval late last week for their new Mazor X Stealth system. He believes that Medtronic is closing the technology gap with Globus Medical (GMED) with the Mazor X Stealth, but he still sees the latter in the lead and thinks new features that Globus intends to introduce this year will keep it there. O'Brien has Overweight ratings on both Globus Medical and Medtronic.

2018-11-06 10:11:22

IIN

IntriCon

$36.77: -7.585 (-17.10%)

, MDT

Medtronic

$91.89: 0.3 (0.33%)

10:11

11/06/18

11/06

10:11

11/06/18

10:11

Stifel still upbeat on IntriCon's long-term prospects after Q3 report

Stifel analyst Jonathan Block said IntriCon's (IIN) stock might see some selling pressure after the company's Q3 revenue of $30.1M came in modestly below his $30.5M forecast, but he remains upbeat on the company's long-term prospects given his view that it is still very early in the process of IntriCon benefiting from Medtronic's (MDT) 670G/690G product cycles. Block keeps a Buy rating and $70 price target on shares of IntriCon, which are down $9.77, or 22%, to $34.52 in morning trading.

IIN

IntriCon

$36.77: -7.585 (-17.10%)

MDT

Medtronic

$91.89: 0.3 (0.33%)

IIN IntriCon

$36.77: -7.585 (-17.10%)

08/22/18: RILY

09/11/18: DOTC

09/17/18: RILY

09/21/18: STFL

MDT Medtronic

$91.89: 0.3 (0.33%)

10/15/18: LEHM

10/16/18: LEHM

10/16/18

11/05/18: PIPR

TODAY'S FREE FLY STORIES

ALB Albemarle $88.17 5.35 (6.46%) 14:54 02/21/19 02/21 14:54 02/21/19 14:54 Recommendations	Albemarle analyst commentary » Albemarle price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 27 Feb 27 Feb
PBR Petrobras $16.70 -0.01 (-0.06%) 14:53 02/21/19 02/21 14:53 02/21/19 14:53 Periodicals	Brazil minister says Petrobras TOR auction may occur in late 2019, Reuters says » Brazil's Energy and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	28 Feb
TI Telecom Italia $5.92 -0.12 (-1.99%) 14:51 02/21/19 02/21 14:51 02/21/19 14:51 Hot Stocks	Telecom Italia sees organic group EBITDA to decrease low single digit in 2019 » TIM's Board of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
TSU Tim Participacoes $16.30 0.03 (0.18%) 14:50 02/21/19 02/21 14:50 02/21/19 14:50 Hot Stocks	Breaking Hot Stocks news story on Tim Participacoes » TIM Participacoes trading… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
ROKU Roku $51.60 -2.03 (-3.79%) 14:49 02/21/19 02/21 14:49 02/21/19 14:49 Options	Roku options imply 18.8% move in share price post-earnings, below median historical move » Pre-earnings options… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb

LKSD LSC Communications $9.23 -0.17 (-1.81%) , QUAD Quad/Graphics $15.85 -0.42 (-2.58%) 14:47 02/21/19 02/21 14:47 02/21/19 14:47 Conference/Events	Quad/Graphics to host special shareholder meeting » Special Shareholder… LKSD LSC Communications $9.23 -0.17 (-1.81%) QUAD Quad/Graphics $15.85 -0.42 (-2.58%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb 22 Feb
FB Facebook $160.21 -2.4 (-1.48%) 14:46 02/21/19 02/21 14:46 02/21/19 14:46 Periodicals	Kids advocacy groups urge FTC to probe Facebook over game purchases, Adweek says » Childrens' advocacy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 25 Feb 03 Mar
QUAD Quad/Graphics $15.80 -0.47 (-2.89%) , LKSD LSC Communications $9.23 -0.17 (-1.81%) 14:41 02/21/19 02/21 14:41 02/21/19 14:41 Conference/Events	LSC Communications to host special shareholder meeting » Special Shareholder… QUAD Quad/Graphics $15.80 -0.47 (-2.89%) LKSD LSC Communications $9.23 -0.17 (-1.81%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	22 Feb
GIL Gildan Activewear $34.04 -0.13 (-0.38%) 14:37 02/21/19 02/21 14:37 02/21/19 14:37 Downgrade	Gildan Activewear rating change » Gildan Activewear… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
TSU Tim Participacoes $16.30 0.03 (0.18%) 14:37 02/21/19 02/21 14:37 02/21/19 14:37 Earnings	Tim Participacoes releases guidance for 2019-2021 » In a regulatory filing,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

CTRP Ctrip $32.55 -1.24 (-3.67%) 14:35 02/21/19 02/21 14:35 02/21/19 14:35 Options	Ctrip.com put volume heavy and directionally bearish » Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	04 Mar 04 Mar 20 Mar
NAII Natural Alternatives International $11.15 (0.00%) 14:34 02/21/19 02/21 14:34 02/21/19 14:34 Hot Stocks	Natural Alternatives International hires David Brook for sports nutrition unit » Natural Alternatives… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
NTDOY Nintendo $0.00 (0.00%) 14:24 02/21/19 02/21 14:24 02/21/19 14:24 Hot Stocks	Nintendo of America president, COO Reggie Fils-Aime to retire » Nintendo announced that,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
FCAU Fiat Chrysler $14.83 -0.21 (-1.40%) 14:23 02/21/19 02/21 14:23 02/21/19 14:23 Hot Stocks	Fiat Chrysler to propose EUR0.65 per share dividend » Fiat Chrysler Automobiles… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
EWZ MSCI Brazil Index $43.43 -0.32 (-0.73%) 14:20 02/21/19 02/21 14:20 02/21/19 14:20 Options	20K iShares Brazil Fund Mar 44 - 46 call spreads sold at 60c » 20K iShares Brazil Fund… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

$NSD NASDAQ Market Internals $0.00 (0.00%) 14:17 02/21/19 02/21 14:17 02/21/19 14:17 Technical Analysis	NASDAQ market internals summary » Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
$NYE NYSE Market Internals $0.00 (0.00%) 14:16 02/21/19 02/21 14:16 02/21/19 14:16 Technical Analysis	NYSE market internals summary » Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
BZUN Baozun $34.55 -1.08 (-3.03%) 14:15 02/21/19 02/21 14:15 02/21/19 14:15 Options	Baozun put volume heavy and directionally bearish » Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
THRM Gentherm $44.16 1.3 (3.03%) 14:11 02/21/19 02/21 14:11 02/21/19 14:11 Downgrade	Gentherm rating change » Craig-Hallum downgrades… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 01 Mar
PTC PTC $91.88 0.04 (0.04%) 14:08 02/21/19 02/21 14:08 02/21/19 14:08 Hot Stocks	New offering from PTC and ANSYS brings real-time simulation to design engineers » PTC announced the release… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Mar 14 Mar

HSC Harsco $24.48 2.54 (11.58%) 14:06 02/21/19 02/21 14:06 02/21/19 14:06 Recommendations	Harsco analyst commentary » Harsco has opportunity to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
THRM Gentherm $44.10 1.24 (2.89%) 14:06 02/21/19 02/21 14:06 02/21/19 14:06 Downgrade	Gentherm rating change » Gentherm downgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb 01 Mar
SPX S&P 500 $0.00 (0.00%) , SPY SPDR S&P 500 ETF Trust $277.66 -0.76 (-0.27%) 14:04 02/21/19 02/21 14:04 02/21/19 14:04 Periodicals	CEO of container ship giant Maersk sees global trade war escalation, FT says » Moller-Maersk CEO Soren… SPX S&P 500 $0.00 (0.00%) SPY SPDR S&P 500 ETF Trust $277.66 -0.76 (-0.27%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TSU Tim Participacoes $16.28 0.01 (0.06%) 13:58 02/21/19 02/21 13:58 02/21/19 13:58 Hot Stocks	Breaking Hot Stocks news story on Tim Participacoes » TIM Participacoes trading… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
T AT&T $30.85 -0.01 (-0.03%) 13:55 02/21/19 02/21 13:55 02/21/19 13:55 Hot Stocks	AT&T sees discontinuing 3G service in early 2022 » In a regulatory filing… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	25 Feb 11 Mar 11 Mar 20 Mar

Events

Earnings calls, analyst events, roadshows and more

CVI
Today at 15:00

CVR Energy - CVI Conference Calls
IGLD
Today at 15:00

Internet Gold Ltd. Firm Sponsored Meetings

2 Dov Friedman Street, Ramat Gan, OTHER
LQDT
Today at 15:00

Liquidity Services Inc. Firm Sponsored Meetings

6931 Arlington Road, Suite 200, Bethesda, MD
ESV
Today at 16:00

Ensco plc Firm Sponsored Meetings

One Hamilton Place, Park Lane, London
NVRO
Today at 16:30

Nevro - NVRO Conference Calls
ACIA
Today at 16:30

Acacia Communications - ACIA Conference Calls
AL
Today at 16:30

Air Lease - AL Conference Calls
NHTC
Today at 16:30

Natural Health Trends - NHTC Conference Calls
CYTK
Today at 16:30

Cytokinetics - CYTK Conference Calls
MDRX
Today at 16:30

Allscripts - MDRX Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	AI X AI Arlington Asset Investment Spot Secondary Managers: Morgan Stanley & JMP Securities Priced at: $8.33 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ARR X ARR ARMOUR Residential Spot Secondary Managers: Morgan Stanley & Barclays, Citi, Credit Suisse, Goldman Sachs & JPMorgan Priced at: $20.33 7.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CPT X CPT Camden Property Spot Secondary Managers: BofA/Merrill & Deutsche Bank Priced at: $97.85 3.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NRZ X NRZ New Residential Spot Secondary Managers: Morgan Stanley, Credit Suisse & JPMorgan Priced at: $16.50 40.3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OVID X OVID Ovid Therapeutics Spot Secondary Managers: Cowen & William Blair Priced at: $2.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SNNA X SNNA Sienna Biopharmaceuticals Spot Secondary Managers: Cowen & BMO Capital Priced at: $2.50 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	RWLK X RWLK ReWalk Robotics Spot Secondary Managers: H.C. Wainwright Priced at: $.23 19M Shares
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Stifel still upbeat on IntriCon's long-term prospects after Q3 report

TODAY'S FREE FLY STORIES

Get Full Fly Access